Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Revision total joint replacements linked to higher infection risk

Key clinical point: Surgical site infections are most common after revision vs. primary total joint replacement.

Major finding: The 90-day risk of surgical site infection was 5.77 times higher after revision vs. primary total joint replacement.

Study details: Retrospective observational cohort study of 335,134 total knee replacements and 163,547 total hip replacements.

Disclosures: Johnson & Johnson Medical Device Companies provided funding. Three coinvestigators reported employment and stockholder ties to the company. Dr. Edmiston and one coinvestigator reported speaker fees for Ethicon, a Johnson & Johnson company.


Edmiston CE et al. Am J Infect Control. 2019 May 6. doi: 10.1016/j.ajic.2019.03.030.